Falconer N, Barras M, Martin J, Cottrell N. Defining and classifying terminology for medication harm: a call for consensus. Eur J Clin Pharmacol. 2019;75:137–45. https://doi.org/10.1007/s00228-018-2567-5.

Article  CAS  PubMed  Google Scholar 

Silva LT, Modesto ACF, Amaral RG, Lopes FM. Hospitalizations and deaths related to adverse drug events worldwide: systematic review of studies with national coverage. Eur J Clin Pharmacol. 2022;78:435–66. https://doi.org/10.1007/s00228-021-03238-2.

Article  CAS  PubMed  Google Scholar 

Shepherd G, Mohorn P, Yacoub K, May DW. Adverse drug reaction deaths reported in United States vital statistics, 1999–2006. Ann Pharmacother. 2012;46:169–75. https://doi.org/10.1345/aph.1P592.

Article  PubMed  Google Scholar 

Funahashi T, Koyama T, Hagiya H, Harada K, Iinuma S, Ushio S, et al. Population-based observational study of adverse drug event-related mortality in the super-aged society of Japan. Drug Saf. 2021;44:531–9. https://doi.org/10.1007/s40264-020-01037-9.

Article  PubMed  Google Scholar 

US Department of Health and Human Services, Office of Disease Prevention and Health Promotion. National action plan for adverse drug event prevention. 2014. https://health.gov/our-work/national-health-initiatives/health-care-quality/adverse-drug-events/national-ade-action-plan. Accessed 10 May 2023.

Duensing K, Twillman R, Ziegler S, Cepeda MS, Kern D, Salas M, et al. An examination of state and federal opioid analgesic and continuing education policies: 2016–2018. J Pain Res. 2020;13:2431–42. https://doi.org/10.2147/JPR.S267448.

Article  PubMed  PubMed Central  Google Scholar 

Sommer H, Dwenger A. Action plan of the Federal Ministry of Health for improvement of medication safety in Germany: an inventory. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61:1062–5. https://doi.org/10.1007/s00103-018-2778-z.

Article  PubMed  Google Scholar 

Akishita M. Guidelines for medical treatment and its safety in the elderly. Nihon Ronen Igakkai Zasshi. 2007;44:31–4. https://doi.org/10.3143/geriatrics.44.31.

Article  PubMed  Google Scholar 

WHO. WHO Mortality Database. https://www.who.int/data/data-collection-tools/who-mortality-database. Accessed 24 June 2021.

Hohl CM, Karpov A, Reddekopp L, Doyle-Waters M, Stausberg J. ICD-10 codes used to identify adverse drug events in administrative data: a systematic review. J Am Med Inform Assoc. 2014;21:547–57. https://doi.org/10.1136/amiajnl-2013-002116.

Article  PubMed  Google Scholar 

United Nations. World population prospects 2019. https://www.un.org/development/desa/pd/news/world-population-prospects-2019-0. Accessed 20 June 2021.

Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83:171–7.

PubMed  PubMed Central  Google Scholar 

Omar BA, Cynthia BP, Alan DL, Christopher JM, Rafael L, Mie I. Age standardization of rates: a new WHO standard. 2001. https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/gpe_discussion_paper_series_paper31_2001_age_standardization_rates.pdf. Accessed 1 Dec 2022.

Cleveland WS, Devlin SJ. Locally weighted regression: an approach to regression analysis by local fitting. J Am Stat Assoc. 1988;83:596–610. https://doi.org/10.1080/01621459.1988.10478639.

Article  Google Scholar 

Barco S, Mahmoudpour SH, Valerio L, Klok FA, Münzel T, Middeldorp S, et al. Trends in mortality related to pulmonary embolism in the European region, 2000–15: analysis of vital registration data from the WHO Mortality Database. Lancet Respir Med. 2020;8:277–87. https://doi.org/10.1016/S2213-2600(19)30354-6.

Article  PubMed  Google Scholar 

Kuklik N, Stausberg J, Jöckel KH. Adverse drug events in German hospital routine data: a validation of International Classification of Diseases, 10th Revision (ICD-10) diagnostic codes. PLoS ONE. 2017;12: e0187510. https://doi.org/10.1371/journal.pone.0187510.

Article  CAS  PubMed  PubMed Central  Google Scholar 

CDC. NCHS. Provisional drug overdose death counts. In: National Vital Statistics System. Vital statistics rapid release. Surveillance activities. 2023. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Accessed 23 Sep 2023.

FDA Adverse Event Reporting System (FAERS). U.S. Food & Drug Association. 2021. https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-public-dashboard. Accessed 24 Sep 2023.

VigiBase. Uppsala Monitoring Centre. 2021. https://who-umc.org/vigibase/vigibase-who-s-global-database/. Accessed 25 Sep 2023.

Chang AY, Cowling K, Micah AE, Chapin A, Chen CS, Ikilezi G, et al. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050. Global Burden of Disease Health Financing Collaborator Network. Lancet. 2019;393:2233–60. https://doi.org/10.1016/S0140-6736(19)30841-4.

Article  Google Scholar 

OECDiLibrary. Health at a glance 2021: OECD indicators. Pharmaceutical consumption. 2021. https://www.oecd-ilibrary.org/sites/5689c05c-en/index.html?itemId=%2Fcontent%2Fcomponent%2F5689c05c-en#. Accessed 25 Sep 2023.

Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009;48:143–57. https://doi.org/10.2165/00003088-200948030-00001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Turner JP, Tannenbaum C. Older adults’ awareness of deprescribing: a population-based survey. J Am Geriatr Soc. 2017;65:2691–6. https://doi.org/10.1111/jgs.15079.

Article  PubMed  PubMed Central  Google Scholar 

Hannah R, Max R. Opioids, cocaine, cannabis and illicit drugs; 2022. https://ourworldindata.org/illicit-drug-use. Accessed 14 May 2023.

Steinman MA, Miao Y, Boscardin WJ, Komaiko KD, Schwartz JB. Prescribing quality in older veterans: a multifocal approach. J Gen Intern Med. 2014;29:1379–86. https://doi.org/10.1007/s11606-014-2924-8.

Article  PubMed  PubMed Central  Google Scholar 

Spencer MR, Miniño AM, Warner M. Drug overdose deaths in the United States, 2001–2021. NCHS Data Brief, vol 457. Hyattsville: National Center for Health Statistics; 2022. p. 1–8. https://doi.org/10.15620/cdc:122556. Accessed 14 May 2023.

Office for National Statistics. Deaths related to drug poisoning in England and Wales: 2019 registrations. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsrelatedtodrugpoisoninginenglandandwales/2019registrations. Accessed 25 May 2023.

Federal, Provincial, and Territorial Special Advisory Committee on the Epidemic of Opioid Overdoses. Opioid- and stimulant-related harms in Canada. 2023. https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/. Accessed 25 May 2023.

Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Death rate maps & graphs. https://www.cdc.gov/drugoverdose/deaths/2013-2017-increase.html. Accessed 24 May 2023.

The European Monitoring Centre for Drugs and Drug Addiction; 2022: overdose deaths. Statistical Bulletin. https://www.emcdda.europa.eu/data/stats2022/drd_en.24 Accessed May 2023.

Chrzanowska A, Man N, Sutherland R, Degenhardt L, Peacock A. Trends in drug-induced deaths in Australia, 1997–2019. 2021. Drug trends bulletin series. https://ndarc.med.unsw.edu.au/resource-analytics/trends-drug-induced-deaths-australia-1997-2019. Accessed 22 May 2023.

Khan MAA, Hamid S, Babar ZU. Pharmacovigilance in high-income countries: current developments and a review of literature. Pharmacy. 2023;11:10. https://doi.org/10.3390/pharmacy11010010.

Article  PubMed  PubMed Central  Google Scholar 

Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556–64. https://doi.org/10.1056/NEJMsa020703.

Article  PubMed  Google Scholar 

Dequito AB, Mol PGM, van Doormaal JE, Zaal RJ, van den Bemt PM, Haaijer-Ruskamp FM, et al. Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands. Drug Saf. 2011;34:1089–100. https://doi.org/10.2165/11592030-000000000-00000.

Article  PubMed  Google Scholar 

Insani WN, Whittlesea C, Alwafi H, Man KKC, Chapman S, Wei L. Prevalence of adverse drug reactions in the primary care setting: a systematic review and meta-analysis. PLoS ONE. 2021;16: e0252161. https://doi.org/10.1371/journal.pone.0252161.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hodkinson A, Tyler N, Ashcroft DM, Keers RN, Khan K, Phipps D, et al. Preventable medication harm across health care settings: a systematic review and meta-analysis. BMC Med. 2020;18:313. https://doi.org/10.1186/s12916-020-01774-9.

Article  PubMed  PubMed Central  Google Scholar